# clm_BEFBDF4F70C1

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: agreement  
value: CymaBay Therapeutics, Inc.  
valid_from: 2024-02-11  
valid_to: null  
published: 2024-02-12  
recorded: 2026-11-08  
confidence: 0.95  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-09  
cite: AsOf. "Gilead Sciences agreement: CymaBay Therapeutics, Inc.", as of 2024-02-11. Claim clm_BEFBDF4F70C1, https://asof.is/claim/clm_BEFBDF4F70C1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/882095/000095010324002027/0000950103-24-002027-index.htm.  
checked: 2026-11-09 · its source page states the value and the date  

> On February 11, 2024, Gilead Sciences, Inc., a Delaware corporation (“ Parent ” or “ Gilead ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), among Parent, CymaBay Therapeutics, Inc., a Delaware corporation (the “ Company ”),

What https://www.sec.gov/Archives/edgar/data/882095/000095010324002027/0000950103-24-002027-index.htm says, word for word.

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000095010324002027/0000950103-24-002027-index.htm (primary, SEC EDGAR 8-K, published 2024-02-12)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.